Table 1 Demographic and baseline characteristics
Placebo (N = 3) | GSK3008348 1000 mcg (N = 5) | |
|---|---|---|
Age (years), mean (SD) | 70.3 (3.1) | 73.6 (2.3) |
Males, n (%) | 3 (100) | 4 (80) |
BMI (kg/m2), mean (SD) | 31.4 (1.1) | 27.9 (1.9) |
Race, n (%) | ||
White/Caucasian/European heritage | 3 (100) | 5 (100) |
Lung function | ||
FVC percent predicted (%), median (range) FEV1 percent predicted (%), median (range) DLCO percent predicted (%), median (range) | 92.6 (77.9–93.6) 90.0 (89.8–99.2) 43.3 (43.0–50.1) | 91.0 (78.5–113.4) 99.0 (71.4–123.9) 48.0 (41.7–53.5) |